Achievement of Goals in U.S. Diabetes Care, 1999–2010
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tracking national progress in diabetes care may aid in the evaluation of past efforts and identify residual gaps in care. METHODS: We analyzed data for adults with self-reported diabetes from the National Health and Nutrition Examination Survey and the Behavioral Risk Factor Surveillance System to examine risk-factor control, preventive practices, and risk scores for coronary heart disease over the 1999-2010 period. RESULTS: From 1999 through 2010, the weighted proportion of survey participants who met recommended goals for diabetes care increased, by 7.9 percentage points (95% confidence interval [CI], 0.8 to 15.0) for glycemic control (glycated hemoglobin level <7.0%), 9.4 percentage points (95% CI, 3.0 to 15.8) for individualized glycemic targets, 11.7 percentage points (95% CI, 5.7 to 17.7) for blood pressure (target, <130/80 mm Hg), and 20.8 percentage points (95% CI, 11.6 to 30.0) for lipid levels (target level of low-density lipoprotein [LDL] cholesterol, <100 mg per deciliter [2.6 mmol per liter]). Tobacco use did not change significantly, but the 10-year probability of coronary heart disease decreased by 2.8 to 3.7 percentage points. However, 33.4 to 48.7% of persons with diabetes still did not meet the targets for glycemic control, blood pressure, or LDL cholesterol level. Only 14.3% met the targets for all three of these measures and for tobacco use. Adherence to the recommendations for annual eye and dental examinations was unchanged, but annual lipid-level measurement and foot examination increased by 5.5 percentage points (95% CI, 1.6 to 9.4) and 6.8 percentage points (95% CI, 4.8 to 8.8), respectively. Annual vaccination for influenza and receipt of pneumococcal vaccination for participants 65 years of age or older rose by 4.5 percentage points (95% CI, 0.8 to 8.2) and 6.9 percentage points (95% CI, 3.4 to 10.4), respectively, and daily glucose monitoring increased by 12.7 percentage points (95% CI, 10.3 to 15.1). CONCLUSIONS: Although there were improvements in risk-factor control and adherence to preventive practices from 1999 to 2010, tobacco use remained high, and almost half of U.S. adults with diabetes did not meet the recommended goals for diabetes care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Still, many do not meet the recommended goals for diabetes care [7-9]; in Norway, research has shown that only 20% attain the target for metabolic control for glycated hemoglobin A1c (HbA1c), blood pressure, and lipid level, although the quality of care has improved [8].”
In the citing paper
“there is evidence that measures of 10-year CHD risk among U.S. adults with diabetes have improved signi fi cantly over the past decade (2)”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [2]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
No adjustments are needed for multiple comparisons.
Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Research works printed but not linked: 2
- Ahmann AJ, 2007, Am J Manag Care, 13, S41
- Gary TL, 2003, Ethn Dis, 13, 47
Cited by
Items 901–978 of 978
Management of Type 2 Diabetes: Are we making Progress?
Garg, R. (2016) · Endocrine Practice · doi:10.4158/ep151168.co
Qualls, L. G., Hammill, B. G., Maciejewski, M. L., Curtis, L. H., & Jones, W. S. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164115620980
Hvordan er kvaliteten på diabetesomsorgen?
Birkeland, K. I. (2014) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.13.1435
WITHDRAWN: Internet Diabetes Management: A Practical Approach
Tildesley, H. D., Chow, N., White, A. S., Pawłowska, M., & Ross, S. A. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.04.006 · Cited by 1
RetractedCrespin, D., Christianson, J. B., McCullough, J. S., & Finch, M. D. (2016) · American Journal of Medical Quality · doi:10.1177/1062860616656251
Type I Diabetes and Celiac Disease
Ettinger, S. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803013-4.00003-x
Correspondence: Response to Letter to the Editor by K Scharf
Morton, J. I., & Lebovitz, H. E. (2014)
Patel, K. N. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i7.208
“Diabetes is one of the largest global health emergencies of the 21st century [2] .”
BackgroundFat Type Level: A Simpler Way for Men to Understand Body Shape and Health Risks
Riopelle, D. (2017) · Journal of Obesity and Weight-loss Medication · doi:10.23937/2572-4010.1510017
Towards a personalized assessment of pancreatic function in diabetes
Sheu, C., & Paramithiotis, E. (2017) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2017.1385391
Linari, M. A. (2014) · Universidad Nacional de Lanús. Maestría en Epidemiología, Gestión y Políticas de Salud eBooks · doi:10.18294/rdi.2017.174012
Sone, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99593-x
PREVALENCE OF ATHEROSCLEROTIC CRDIOVASCULAR DISEASE MODIFIABLE MAJOR RISK FACTORS: A REVIEW.
Alamoudi, M. A. (2018) · International Journal of Advanced Research · doi:10.21474/ijar01/6415
To address poor blood glucose control, look for clinical inertia
D’Arrigo, T. (2018) · Pharmacy Today · doi:10.1016/j.ptdy.2018.06.013
End-Stage Renal Failure in the Diabetic Patient
Williams, M. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-39154-2.00064-3
Evaluation and Treatment of Insulin Resistance and Hyperglycemic States
Hurley, D. L., & Zangeneh, F. (2018) · Springer eBooks · doi:10.1007/978-3-319-95655-8_13
Montvida, O. (2018) · Queensland University of Technology · doi:10.5204/thesis.eprints.122920
Medina, O., Chávez, G. E. M., Morales, M. E. O., Hernández, G. G. B., Moreno, E. A. R., & Mancias, L. A. A. (2019) · Revista Científica de la Escuela Universitaria de las Ciencias de la Salud · doi:10.5377/rceucs.v5i2.7649
The combination of coronary artery disease and type 2 diabetes: a therapeutic challenge
Johansson, I., & Cosentino, F. (2019) · European Heart Journal Supplements · doi:10.1093/eurheartj/suz037
Medizin, S. (2015) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-015-1527-1
Bariatric Surgery: Clinical Presentation and Evaluation
Corpo, M. D., Schlottmann, F., & Patti, M. G. (2019) · Springer eBooks · doi:10.1007/978-3-030-27592-1_25
Jeon, D. S. (2020) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2020.2.e4
Muñoz, C. A. V., & Romero, M. (2019) · Revista de investigación universitaria en salud. · doi:10.56487/x5f1g555
Moving Beyond the Individual Level With Uncontrolled Diabetes
Wadas, T. M., Andrabi, M. S., & Appel, S. J. (2020) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2020.06.015
Glycaemic control in diabetes - Bridging the gap
Raizada, N., & Khadgawat, R. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_4719_20
de Lima, L. F. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2015.tde-02122020-114107
Study Comparing the Liver Enzymes in Hypertensive and Normotensive Patients with Type 2 Diabetes
Ahmed, R. (2021) · International Journal of Research and Review · doi:10.52403/ijrr.20210728
“Patients who have controlled glycemia, blood pressure or cholesterol levels and without smoking are only 14% [3] .”
BackgroundEvolution of Glycemic Targets in Management of Diabetes
Masood, M. Q. (2021) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2021.115018
“seems to be plateaued in subsequent assessments in 2015-2018 surveys [36] [37].”
BackgroundRomeo, G. R., Silva, P. S., & Cavallerano, J. D. (2021) · Springer eBooks · doi:10.1007/978-3-319-90495-5_294-1
Nigoo, K. A., Chafekar, N. D., & Kirloskar, M. (2021) · MVP Journal of Medical Sciences · doi:10.18311/mvpjms/2021/v8i2/308
“MVP Journal of Medical Sciences 257 Vol 8 (2) | July-December 2021 | https://mvpjms.”
BackgroundInfluentialMoszczynski, P., & Tabarowski, Z. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812019-4.00032-5 · Cited by 2
Dietary Therapy of Diabetes Mellitus
Ebel, F. E., & Strain, G. W. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_41-2
Adimoolam, D., Muthukrishnan, V., & Albu, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_8
Adimoolam, D., Muthukrishnan, V., & Albu, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-20797-1_8-1
Vijay, S. (2019) · Diabetes & Obesity International Journal · doi:10.23880/doij-16000218
Johnston, E. A., Roque, N. A., Cole, B. H., Flanagan, M., Kris‐Etherton, P. M., & Petersen, K. H. (2022) · Diabetology · doi:10.3390/diabetology3040038
“Only about half of US adults with diabetes meet evidence-based standards for glycemic control [3].”
BackgroundMaximous, M., Webster, J., Hsu, J. Y., Chung, J., & Chock, B. (2023) · The Permanente Journal · doi:10.7812/tpp/22.088
Rodríguez‐Saldaña, J. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_1 · Cited by 1
Type 1 and Type 2 Diabetes Mellitus
Comoglio, M., Monge, L., & Longhi, E. V. (2023) · Springer eBooks · doi:10.1007/978-3-031-31307-3_11
Jha, S. C., Kumar, N., Kumar, P., & Yadav, A. K. (2023) · Student s Journal of Health Research Africa · doi:10.51168/sjhrafrica.v4i12.973
Daneshvar, M., Naddafi, M., & Ghadimi, M. (2024) · Qeios · doi:10.32388/a433s7.2
Daneshvar, M., Naddafi, M., & Ghadimi, M. (2024) · Qeios · doi:10.32388/a433s7
“Dyslipidemia can increase the risk of developing CVD and related complications, primarily through the progression of atherosclerosis [2][3] .”
BackgroundQammar, N., Zain, M., Jabeen, R., Deeba, F., Iqbal, N., Javeed, H. M. R., Alatawi, F. S., Alatawi, M. S., Almowallad, S. J., Alharbi, A. A., et al. (2024) · Cellular and Molecular Biology · doi:10.14715/cmb/2024.70.2.4
“Common conditions that coexist with type-2 diabetes such as dyslipidemia and hypertension are clear CAD risk factors and diabetes confers the independent risk [20].”
BackgroundViñoles, F. C., Avila, J. R., Santiago, D., Vilera, N., Réquiz, Z. A., & Camperos, P. (2023) · Diabetes actual · doi:10.61156/2023.1.1.001
Secular trends in adherence to healthy behaviors among US adults with diabetes, 1999-2018
Feng, C., Feng, L., Shan, Z., Han, H., Cao, Y., Sheng, A., Guasch‐Ferré, M., Geng, X., Wang, L., & Zong, G. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae090 · Cited by 1
Arero, A. G., Rabizadeh, S., Sorato, M. M., AlJasem, M., Arero, G., Esteghamati, A., & Nakhjavani, M. (2024) · Journal of Diabetes and Endocrine Practice · doi:10.1055/s-0044-1791692
Westall, S., Watmough, S., Narayanan, R. P., Irving, G. J., & Hardy, K. J. (2025) · medRxiv · doi:10.1101/2025.01.11.24319632
Diabetes Self-Management Education and Behavior Change
Rodriguez, K., & Drobycki, N. (2020) · American Diabetes Association eBooks · doi:10.2337/9781580406314.ch06
Majd, Z., Cheruvu, S. S., Chen, H., Johnson, M. L., Birtcher, K. K., Serna, O., & Abughosh, S. (2026) · Current Medical Research and Opinion · doi:10.1080/03007995.2026.2682989
Li, Z., Sun, R., Huang, T., Han, Z., Xuan, X., & Huang, C. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/8517492
Román, C. L. (2015) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/44617
Yang, C.-Y., Su, P.-F., Hung, J.-Y., Ou, H.-T., & Kuo, S. (2020) · Figshare · doi:10.6084/m9.figshare.12617720
Ferdinand, K. C., Dunn, J., Nicolay, C., Sam, F., Blue, E. K., & Wang, H. (2023) · Figshare · doi:10.6084/m9.figshare.22624691
Additional file 2 of Predictors of lack of glycemic control in persons with type 2 diabetes
Louie, J. Z., Shiffman, D., Rowland, C. M., Kenyon, N. S., Bernal‐Mizrachi, E., McPhaul, M. J., & Garg, R. (2024) · Figshare · doi:10.6084/m9.figshare.25059570
Li, B., Zhou, C., Gu, C., Cheng, X., Wang, Y., Li, C., Ma, M., Fan, Y., Xu, X., Chen, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24934159
Additional file 1 of Predictors of lack of glycemic control in persons with type 2 diabetes
Louie, J. Z., Shiffman, D., Rowland, C. M., Kenyon, N. S., Bernal‐Mizrachi, E., McPhaul, M. J., & Garg, R. (2024) · Figshare · doi:10.6084/m9.figshare.25059450
Gentile, M., D’Angelo, M., Varì, M. R., Bolla, A. M., Bianco, M., & Scarpioni, R. (2025) · Diabetology · doi:10.3390/diabetology6120144
“RAASi are also able to prevent the development of microalbuminuria in normotensive patients; for this reason they should be used either in patients with hypertension or nephropathy [28].”
Feasibility of glycated haemoglobin target-setting in adults with diabetes: A mixed-methods study
Westall, S., Watmough, S., Narayanan, R. P., Irving, G. J., & Hardy, K. J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0317162
“It was found that none of the confounding variables significantly predicted change in W-BQ12 energy score (F[5,27] =.36, p = ns).”
InfluentialNarres, M., Kvitkina, T., Claessen, H., Ubach, E., Georg, W., Metzendorf, M., Richter, B., Roden, M., & Icks, A. (2026) · Systematic Reviews · doi:10.1186/s13643-026-03089-x · Cited by 3
“…blood pressure and dyslipidemia therapy in combination with improved lifestyle factors, such as weight reduction, increased physical activity, dietary changes, stress management, and smoking cessation, were described as important factors for the prevention of AMI in people with diabetes [59–63].”
Optimizing Diabetes Management: Insights from a Prospective Study
Saadaoui, L., Melki, F. Z., Aynaou, H., & Salhi, H. (2026) · Case Reports in Clinical Medicine · doi:10.4236/crcm.2026.152007
Berg, D. D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-87862-3.00008-2
GLP-1 Receptor Agonist and SGLT2 Inhibitor Combination Therapy in Type 2 Diabetes Management
Latricia, M. (2026) · IAA Journal of Biological Sciences · doi:10.59298/iaajb/2026/14145454
Pham, T. T. T., & Soo, K. H. (2026) · Journal of Control Engineering and Applied Informatics · doi:10.61416/ceai.v28i1.9701
Epidemiology of Cardiovascular disease and associated risk factors in Gaza Strip- Palestine
Jamee, A. (2019) · theses.fr (ABES) · doi:10.70675/f3c10b16z6420z46b0z81b5z75ec59d4399e
Sone, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00162-x
Goldney, J., Hamza, M., Sarkar, P., Morgan, H. D., Green, N., Ridgeway, J., Alabraba, V., Willcocks, L., Chandracant, K., Javed, K., et al. (2026) · Diabetic Medicine · doi:10.1111/dme.70347
“15,16 Individuals with EOT2D are less likely to take prescribed medications or attend appointments.”
Pillay, S., & Dlamini, S. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02309-8
“Studies from diverse contexts show that a substantial proportion of individuals undergoing care for dysglycaemia have HbA1c values above recommended thresholds [1, 10].”
Prato, S. D., Heine, R. J., Manghi, F. P., Hsia, S. H., Valderas, E. G., Zeytinoglu, M., Razzoli, E., Kiljanski, J. I., Sharma, P., Knights, A. W., et al. (2026) · Annals of Internal Medicine · doi:10.7326/annals-25-05602
Therapeutic Inertia in Chronic Disease Management
Zoukh, I. M., Awaisu, A., Owusu, Y., Hadi, M. A., & Dabbous, Z. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-26472-6.00061-9
Das, S., Tripathy, D., & Ponnu, P. (2026) · Cureus · doi:10.7759/cureus.110769
“This logic has since been extended to diabetes, tuberculosis, hepatitis C, mental health disorders, and virtually every major chronic disease area [7-11].”
Tuyizere, A., Bitew, H. Y., Sebera, E., Bangamwabo, B., Dushimimana, O., Mukantwali, C., Uwamaliya, L., Igihozo, S., Belay, K. E., Murorunkwere, L., et al. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02435-3
“A study analyzed achievement of diabetes care goals in United States diabetic patients from 1999 to 2010 showed almost a half of patients didn’t meet the diabetes care goals despite there was an improvement in adherence to preventive practices [17].”
Mousa, A. H. (2025) · Al-Turath Journal of Nursing · doi:10.63964/atjn.2025.4.2
Igna, A. D., Petca, B.-L., Popovici, P.-A., Ghitea, T. C., Brata, R. D., Trifan, D. F., & Popoviciu, M. S. (2026) · Diseases · doi:10.3390/diseases14090329
Treatment and practical considerations of IgA nephropathy
Sawaf, H., Kim, J., Mehdi, A., Cavanaugh, C. J., & Taliercio, J. J. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1911077
BindingDB (2021) · UC San Diego · doi:10.7270/q2154mmp
Nguyễn, T. P. O., Ngọc, N. M., Thới, Đ. V., Nguyễn, T. P. O., Nguyễn, T. P. O., & Minh, N. N. (2026) · Tạp chí Y học Dự phòng · doi:10.51403/0868-2836/2026/3501
Metadata
- Authors
- Ali, M. K., Bullard, K. M., Saaddine, J. B., Cowie, C. C., Imperatore, G., & Gregg, E. W.
- Affiliations
- Centers for Disease Control and Prevention (US)
- National Institutes of Health (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-04-25
- Volume
- 368
- Issue
- 17
- Pages
- 1613-1624
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2124234371
- Cited by
- 979
- References
- 40
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 31 · 2023: 45 · 2022: 57 · 2021: 61 · 2020: 77 · 2019: 106 · 2018: 98 · 2017: 112 · 2016: 106 · 2015: 112 · 2014: 97 · 2013: 33
- FWCI
- 91.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes management, glycemic control, HbA1c, blood pressure control, LDL cholesterol, tobacco use, coronary heart disease risk, preventive medicine, annual eye examination, foot examination, influenza vaccination, pneumococcal vaccination, self-monitoring of blood glucose, health disparities, NHANES, Behavioral Risk Factor Surveillance System
- MeSH terms
- Adolescent, Adult, Aged, Diabetes Mellitus, Female, Health Promotion, Glycated Hemoglobin, Humans, Male, Middle Aged, Nutrition Surveys, Patient Compliance, Risk Factors, Socioeconomic Factors, United States, Body Mass Index, Outcome Assessment, Health Care, Age Distribution, Sex Distribution, Quality Indicators, Health Care, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.